Home / AUROPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AUROPHARMA.NS make money? Does AUROPHARMA.NS have pricing power? What's the Earnings Whisper? Will AUROPHARMA.NS profit more as the business scales? What is AUROPHARMA.NS's management track record? Is AUROPHARMA.NS's current price justified?

Aurobindo Pharma Limited

₹1666.9 +$473.90 (+39.72%)

NSE · 16 Oct 2026 09:58 UTC

Previous Close

₹1677.9

Day Range

₹1655₹1681.7

Year Range

₹1080.1₹1740

Market Cap

959.1B

AVG Volume

1.04M

Trailing/Forward PE

26.05/18.28

PEG ratio

0.89

Dividend Yield

Next Earnings Date

2026-11-14

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

AUROPHARMA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	348.91B
26 Q4	336.53B
26 Q3	331.82B
26 Q2	325.14B
26 Q1	320.25B
25 Q4	317.24B
25 Q3	309.22B
25 Q2	302.95B
25 Q1	297.18B
24 Q4	290.02B

Net Income (INR) · TTM

AUROPHARMA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	37.13B
26 Q4	35.05B
26 Q3	34.87B
26 Q2	34.22B
26 Q1	33.91B
25 Q4	34.86B
25 Q3	34.91B
25 Q2	35.82B
25 Q1	35.21B
24 Q4	31.73B

Operating Income (INR) · TTM

AUROPHARMA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	52.74B
26 Q4	72.8B
26 Q3	75.28B
26 Q2	97.51B
26 Q1	119.79B
25 Q4	120.01B
25 Q3	118.98B
25 Q2	115.78B
25 Q1	111.29B
24 Q4	104.5B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Aurobindo Pharma Limited

Video analysis: AUROPHARMA.NS

News: AUROPHARMA.NS

Similar companies